Bioprogress is a stock I have been in and out of quite a few times since it floated in May but not much mention here on the Investors' Room. Does anyone else follow this stock. I see it is up 1.5p today and a few good buyers seem to have appeared.

He gets the chance to enter into dialouge with me a few times a week!

plenty Fred , my 3 kids for a start.

Lol shammy.

Out of these again, 1% profit, other fish to fry :)

do u wrap yer kids in cotton wool dil. Haha u sheepshagger.

bet u live in a pokey flat in the shitty valleys, probably claiming benefit money

no ... a tent on the Brecons

From poster on A D V F N

Click on the link on Question Convention and then on
'Who we are' then click link at bottom

I tried to count the heads, but the machine was moving to fast.! LOL


http://www.whatisfmcmagenta.com/

This thread is very quiet considering the sp has jumped 10% today.

I was going to sell mine at 32 - but might just hang on a bit longer

Baza

Some of the comments from the FMC staff are stunning, they truly believe Nrobe is set to change the whole pharmaceutical industry.

Check out the advfn bulletin board for the details or see them for yourself here!

http://www.whatisfmcmagenta.com/

baza

32p!!!!!!!!!!!!!!

Sell if you want but believe me the FMC deal alone is worth over a quid on the sp, throw in everything else and you honestly think 32p is expensive?

This will be over a pound at year end and over a fiver within a year.

Tried this site http://www.whatisfmcmagenta.com but arrows disappeared at side so i couldnt read alll the page, REALLY ANNOYING. Anyone know how i can solve the problem??? please.

Shamona - hope your right, and gona quote ya on those dates.

You need to click on the word "QUESTION CONVENTION" this will take you into the site.

You then get multiple choices and about half a dozen video's to view.

got past first page, then it wouldnt work, couldnt ead the page page play on the video (right mouse click) im giving up does my head in when you spend ages trying to get something work. but thanks anyway.

I just tried and it works fine, once you're into the site click "our business proposition" then where it says click"here".

This then takes you to 4 videos, click on any to play; no need for right clicking at all.

ta, got it working, still cant see the bottom bit of video and cant cant scroll up and down, but getting there, just need to get my speakers working, not having much luck.

Things are looking very good and hopefully this is the start of the new beginning at last.

up again.
bprg make a presentation at the madrid show, so could there be an announcement tomorrow?

Solid recovery today with some nice chunky buys.

Lemming brief updates 1 November 2005

Stanelco (SEO) continued the roller coaster ride, lost 0.50p to
15p. A small matter of changing its advisor, be it a lazy one,
KBC Peel Hunt to a more proactive Evolution Group whom
have been pretty much by SEO`s side this past year, hardly
missing an opportunity to update investors with progress.
Although the shares have lost their positive momentum, which
seen them rise to giddy heights of 32p earlier this year, the
shares are news driven, and we expect them to put in a new
burst of energy once the BPRG debacle is resolved......even
though we expect BPRG to be the winner. Nevertheless, SEO
have strong IP in GREENSEAL and Starpol 2000, which already
has EU approval, with expected US FDA full approval
imminent.

Prestigious Casino operator London Clubs International (LCI)
looks to be back in favour with speculative punters again. The
shares closed 6p higher, at 127.50p, but off their 52 week high
of 145p, nevertheless, they remain in the money from our 55p
inauguration back in 2003. The shares have woken from their
slumber in recent trading days on the back of renewed
speculation the Malaysian based Genting, is looking to have
another roll of the dice. Genting already has 29.8%, close to a
being forced to show their hand, thus ,make a formal bid. This
could force another predator to show their hand. That is
speculation on our part.

CSR`s positive momentum came to a halt today, even
though the shares had a debut buy note and 840p target
from UBS. This, as you would expect, helped push CSR 45p
yesterday, to 719p. The Swiss broker agrees with what we
have been telling you, that the Bluetooth market, where the
semiconductor maker has a dominant market share, is still in
its infancy. However, the share closed 6.50p lower on profit
taking, at 713p, recording a 332p gain since inauguration in
July 2004.

Doing nicely this morning - Glad I did not sell at 32 - Thanks for the tip Sham

Baza

BioProgress PLC
02 November 2005


BioProgress plc
('BioProgress' or the 'Company')

Grant of Executive and Employee Options

The Board of BioProgress plc (AIM: BPRG; NASDAQ: BPRG), adopted two new share
option schemes on 1 November 2005, the BioProgress plc Employee Share Option
Scheme (the 'Employee Option Scheme') and the Executive Share Option Scheme 2005
(the 'Executive Option Scheme'), and on the same day granted options to
subscribe for 11,000,000 Ordinary Shares of 0.01 pence each in the Company as
set out below to the following directors in respect of the Executive Option
Scheme.

The Executive Option Scheme comprises certain options (totalling 3,500,000
options) exercisable subject to performance criteria which will require the
Company's share price to be no less than 87.3 pence in respect of three out of
five consecutive days following the date of grant ('Performance Options'); and
certain other options (totalling 7,500,000 options) exercisable in two tranches,
an initial 50% with effect from 31 March 2006 and the remaining 50% with effect
from 30 September 2006 ('Non-Performance Options'). The Non-Performance Options
reflect the retirement of an equity issuance scheme which was not taken up by
the directors.

These options were granted at an exercise price of 29.1 pence per share.


Name No. of Performance Options No. of Non-performance Options

Dan Farrow 1,500,000 3,500,000

Richard Trevillion 2,000,000 4,000,000


Mr Farrow now holds a total of 5,000,000 options in the Company. Mr Trevillion
now holds a total of 6,000,000 options in the Company.

The Company will also be making shares available for the grant of options to its
key employees; the Employee Share Option Scheme. These options will be awarded
on an individual achievement basis throughout the Company and used to
incentivise and retain individuals who have and will contribute to the success
of the business going forward.

2 November 2005

For further details please contact:

BioProgress plc 01354 655674
Richard Trevillion, Chief Executive Officer
www.bioprogress.com